Prespecified subset analyses suggest that ipilimumab may be most active ... Intravenous; mCRPC: Metastatic castration-resistant prostate cancer; P: Placebo; PSA: Prostate-specific antigen; q3w ...
BMS has bucked the trend for late-stage immuno-oncology studies in prostate cancer in the CheckMate 650 trial Opdivo in combination with CTLA4 inhibitor Yervoy (ipilimumab), which showed modest ...
Melanoma Among Adult Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study Adults with stage IB-IIIA (American Joint Committee on Cancer seventh edition) resectable NSCLC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback